CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALL

NCT03467256 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

18

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia
Acute Lymphocytic Leukemia, Pediatric

Interventions

BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Tocilizumab
DRUG: Cytarabine
DRUG: Etoposide
DRUG: Dexamethasone

Sponsor

Federal Research Institute of Pediatric Hematology, Oncology and Immunology